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Slaughterhouse wastewater is considered a reservoir for antibiotic‑resistant bacteria and antibiotic 
residues, which are not sufficiently removed by conventional treatment processes. This study focuses 
on the occurrence of ESKAPE bacteria (Enterococcus spp., S. aureus, K. pneumoniae, A. baumannii, P. 
aeruginosa, Enterobacter spp.), ESBL (extended‑spectrum β‑lactamase)‑producing E. coli, antibiotic 
resistance genes (ARGs) and antibiotic residues in wastewater from a poultry slaughterhouse. The 
efficacy of conventional and advanced treatments (i.e., ozonation) of the in‑house wastewater 
treatment plant regarding their removal was also evaluated. Target culturable bacteria were detected 
only in the influent and effluent after conventional treatment. High abundances of genes (e.g., blaTEM, 
blaCTX‑M‑15, blaCTX‑M‑32, blaOXA‑48, blaCMY and mcr-1) of up to 1.48 ×  106 copies/100 mL were detected 
in raw influent. All of them were already significantly reduced by 1–4.2 log units after conventional 
treatment. Following ozonation, mcr-1 and blaCTX‑M‑32 were further reduced below the limit of 
detection. Antibiotic residues were detected in 55.6% (n = 10/18) of the wastewater samples. Despite 
the significant reduction through conventional and advanced treatments, effluents still exhibited 
high concentrations of some ARGs (e.g., sul1, ermB and blaOXA‑48), ranging from 1.75 ×  102 to 3.44 ×  103 
copies/100 mL. Thus, a combination of oxidative, adsorptive and membrane‑based technologies 
should be considered.
Currently, poultry represents one of the main sources of meat production  worldwide1. In the first half of 2020, 
more than 800,000 tons of poultry were processed only in  Germany2. Slaughtering, processing and cleaning and 
sanitizing of poultry production facilities are water-consuming processes. Depending on the slaughtering process, 
between 5,000 and 21,000 L of water per ton of meat is needed for  processing3. This leads to high amounts of 
wastewater that arises along the slaughtering chain, which usually exhibits various enteric  pathogens4. In addition 
to microbiological loads, slaughterhouse wastewater also exhibits a high organic content due to solved fibers, 
proteins, and  fats5. Thus, the direct discharge of untreated livestock wastewater to surface waters is impracti-
cal and should be avoided because of environmental pollution and possible negative effects on human health. 
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Moreover, after the prescribed withdrawal periods, it may further contain residues of antimicrobials commonly 
used in veterinary medicine as well as detergents and  disinfectants6,7.
Interestingly, meat production has changed over the last 30 years, as it has doubled worldwide and is expected 
to double again until  20508. This implies a steadily increasing quantity of produced wastewater, which also forces 
an increase in the pollution loads discharged into the environment. Thus, mostly after pretreatment in on-site 
wastewater treatment plants (WWTPs), slaughterhouses commonly discharge their wastewater either directly 
into a river or other receiving body (direct dischargers) or to municipal WWTPs (indirect dischargers)9,10.
German slaughterhouses commonly treat their wastewater by different physicochemical and/or biological 
methods. This results in a moderate to high removal of nutrients and a reduction of the bacterial load by 1.1–3.4 
log  units6,11,12. Currently, advanced oxidation processes (AOPs) are becoming an interesting additional treatment 
option to the prevailing conventional methods. AOPs (e.g., ozone treatment) are currently discussed as effective 
technologies for inactivation of microorganisms, especially antibiotic-resistant bacteria and  pathogens12. Ozone 
treatment has been shown to exhibit a high reduction efficacy of 98.4% against facultative pathogenic bacteria 
and their antibiotic resistance genes (ARGs)12. In German municipal WWTPs, microbial reduction to below 
the detection limit  (101 cell equivalents per 100 mL) was recently reported in the case of additional advanced 
treatment technologies (ozonation and ultrafiltration)13. Thus, advanced treatment technologies could decrease 
the bacterial loads discharged into the aquatic environment, preventing the dissemination, inter alia, of clini-
cally relevant antibiotic-resistant bacteria and their resistance determinants. However, upgrading WWTPs with 
advanced treatment technologies bears additional costs associated with high energy consumption, additional 
personnel and posttreatment of the  effluents12,14.
Interestingly, in the EU, the use of advanced treatment technologies is not mandatory for operators of WWTPs 
in any sector (e.g., municipal, health care or industry), as no legal limits or reduction levels have been fitted for 
microbiological pollutants in wastewater. However, the occurrence of important pathogenic microorganisms in 
municipal and clinical wastewater is well  documented15. Furthermore, antibiotic-resistant bacteria with zoonotic 
potential are prevalent in livestock  wastewater16. Livestock-associated methicillin-resistant Staphylococcus aureus 
(LA-MRSA), extended-spectrum β-lactamase (ESBL)-producing Escherichia coli/Klebsiella pneumoniae and 
mcr-1-carrying Enterobacterales, exhibiting resistance to highly and critically important antimicrobials, were 
already detected in biologically and physicochemically treated effluents of in-house WWTPs of German poultry 
 slaughterhouses17,18. In addition, Savin et al. reported the detection of antimicrobial residues in wastewater from 
German pig slaughterhouses after conventional treatment in their on-site  WWTPs19. This provides evidence on 
inadequate wastewater treatment by in-house WWTPs that enables further dissemination of clinically relevant 
bacteria of livestock origin and antimicrobial residues into surface waters and the environment.
However, comparable data on the occurrence of antibiotic-resistant facultative pathogenic bacteria and anti-
microbial residues in livestock wastewater before and after treatment by advanced techniques such as ozonation 
are lacking. This study aimed to determine the occurrence of ESKAPE bacteria (Enterococcus spp., S. aureus, K. 
pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter spp.), ESBL-producing E. coli and 
antimicrobial residues in wastewater from a poultry slaughterhouse before and after conventional and advanced 
treatments. Furthermore, the reduction efficacy of the in-house WWTP upgraded with an ozone facility on clini-
cally relevant ARGs and facultative pathogenic bacteria (i.e., E. coli, K. pneumoniae, A. baumannii, P. aeruginosa 
and enterococci) was evaluated.
Results
Detection of target ESKAPE bacteria and their phenotypic resistance. Overall, 97 isolates were 
recovered from water samples of the influent (n = 81) and effluent after physicochemical and biological treat-
ments (n = 16). No target ESKAPE bacteria were detected in the effluent after subsequent ozone treatment. The 
majority of them belonged to the A. calcoaceticus-baumannii complex (ACB complex: 32.0%, 31/97), K. pneumo-
niae (24.7%, 24/97), E. coli (22.7%, 22/97) and S. aureus (14.4%, 14/97). The abundances of the E. cloacae com-
plex and P. aeruginosa were low at 4.1% (4/97) and 2.1% (2/97), respectively. No VRE and CRE were detected.
The phenotypic antimicrobial resistance of the recovered isolates is summarized in Fig. 1. Due to selective 
isolation, high rates of resistance to β-lactams (e.g., PIP and CTX) among isolates of E. coli and K. pneumoniae 
were expected. The highest 3MDRO rate (multidrug-resistant organisms) with combined resistance to PIP, 
CTX and CIP was exhibited by E. coli (40.9%), followed by K. pneumoniae (16.7%). Notably, all isolates were 
susceptible to carbapenems (IMP, MEM), ceftazidime-avibactam, amikacin and tigecycline. Interestingly, 22.7% 
and 20.8% of E. coli and K. pneumoniae isolates, respectively, exhibited resistance to the newly approved drug 
combination ceftolozane-tazobactam. Resistance to colistin was detected only at a low rate among E. coli (9.1%) 
and K. pneumoniae (4.2%) isolates. Furthermore, no 3MDRO phenotype was detected among isolates of the 
ACB complex. Moreover, considering the intrinsic resistance of ACB complex species to temocillin, cefotaxime, 
chloramphenicol and fosfomycin, only a minor percentage of isolates exhibited acquired resistance to ceftazi-
dime and sulfamethoxazole-trimethoprim. Interestingly, in addition to the intrinsic resistance to ampicillin, 
oxacillin, penicillin-G, and cefoxitin, all MRSA isolates were resistant to clindamycin, erythromycin and the 
combination thereof.
Characterization of ARGs in target bacterial species. The majority of E. coli isolates (72.7%, 16/22) 
exhibited a blaTEM genotype, with blaTEM-116 accounting for 27.3%, as well as blaTEM-52 and blaTEM-1 accounting 
for 22.7% each, respectively. blaCTX-M-1 and blaSHV-12 were detected in 13.6% of E. coli isolates. In K. pneumoniae 
(n = 24), only genes of the blaSHV family were identified, with blaSHV-2 accounting for 66.7% and blaSHV-12 account-
ing for 8.3% of the isolates. Six K. pneumoniae isolates (25.0%) tested negative for bla genes encoding SHV, TEM, 
and CTX-M enzymes. Isolates of the E. cloacae complex (n = 4) carried blaSHV-12 (n = 2) and blaTEM-1 (n = 2).
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No blaPER, blaGES, or blaVEB were detected among P. aeruginosa and isolates of the ACB complex. mcr-1.1 was 
detected in one colistin-resistant E. coli (1/2) isolate.
Molecular typing of ESBL‑producing E. coli and MRSA. The majority of E. coli isolates were assigned 
to phylogroups B1 (50.0%) and E (27.3%), which are commonly associated with commensal strains. Less abun-
dant phylogroups were represented by A and F (each 9.1%) as well as C (4.5%). Notably, extraintestinal patho-
genic (ExPEC) groups B2 and D were not detected.
Recovered MRSA isolates (n = 14) belonged to the clonal complexes CC9 (t1430 and t13177, each 35.7%) 
and CC398 (t034, 28.6%).
Abundance of ARGs in water samples. According to Hembach et al.13, the abundance of “frequent” 
ARGs in influent, effluent after physicochemical and biological treatments, and subsequent ozone treatment is 
shown in Fig. 2. All measurements were performed after PMA treatment for living/dead discrimination. ermB 
and blaTEM exhibited the highest abundances of 5.61 ×  106 and 1.48 ×  106 gene copies per 100 mL, respectively, 
followed by sul1 (4.98 ×  105) and tetM (9.25 ×  104). After physicochemical and biological treatments, the highest 
significant reduction of 3.7 log units was achieved for blaTEM (p < 0.001), followed by ermB and tetM (each 2.7 
log units) as well as sul1 (1 log unit). After the subsequent ozonation, blaTEM, sul1 (both p < 0.001) and ermB 
(p < 0.05) were further significantly reduced (6.6 – 34.4-fold).
Figure 1.  Phenotypic resistance to antimicrobial agents detected among isolates of (A) E. coli, (B) K. 
pneumoniae, (C*) ACB complex and (D**) MRSA. Abbreviations for antimicrobial agents: TEM temocillin, 
PIP piperacillin, TZP piperacillin-tazobactam, CTX cefotaxime; CAZ ceftazidime; CZA ceftazidime-avibactam; 
C/T ceftolozane-tazobactam; IMP imipenem, MEM meropenem, AMK amikacin, TGC tigecycline, CIP 
ciprofloxacin, LVX levofloxacin, CHL chloramphenicol, SXT sulfamethoxazole-trimethoprim, FOF fosfomycin, 
CST colistin, AMP ampicillin, GEN gentamicin; OXA oxacillin, TEC teicoplanin, PEN-G penicillin G, FA fusidic 
acid, LZD linezolid, DAP daptomycin, CPT ceftaroline,, VAN vancomycin, RIF rifampicin, MUP mupirocin, 
FOX cefoxitin; MXF moxifloxacin, CLI clindamycin; ERY erythromycin, Q-D synercid (quinupristin-
dalfopristin). *Species of the ACB complex are considered intrinsically resistant to temocillin, cefotaxime, 
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The abundance of “intermediate and rare abundant” ARGs in the analysed samples is shown in Fig. 3. 
blaCTX-M-32 and mcr-1 were detected with the highest abundances of 3.58 ×  104 and 3.17 ×  104 gene copies per 
100 mL, respectively, followed by blaOXA-48 (6.65 ×  103), blaCMY-2 (4.07 ×  103), blaCTX-M-15 (9.97 ×  102), and vanA 
(1.30 ×  102) gene copies per 100 mL. However, all of them were significantly reduced after physicochemical and 
biological treatments (p < 0.001), with reduction factors ranging from 2.2 log units in the case of carbapenemase 
blaOXA-48 to 4.2 log units in the case of blaCTX-M-32. Furthermore, blaCTX-M-15 and vanA were reduced to under the 
limit of detection (LOD). After subsequent ozonation, blaCTX-M-32 (p < 0.05) and mcr-1 (p < 0.001) were signifi-
cantly reduced < LOD.
Figure 2.  Abundance of “frequent” antibiotic resistance genes in influent and effluent after physicochemical 
and biological treatments and subsequent ozone treatment. Displayed are mean values with standard 
deviation. Significance is given by one-tailed nonparametric Mann–Whitney U test calculation and is shown 
by asterisks (*p ≤ 0.05, **p ≤ 0.001). Compared are gene copies per 100 mL in (i) raw influent with effluent after 
physicochemical and biological treatments and (ii) in effluent after physicochemical and biological treatments 
with effluent after subsequent ozone treatment.
Figure 3.  Abundance of “intermediate and rare abundant” antibiotic resistance genes in influent and effluent 
after physicochemical and biological treatments and subsequent ozone treatment. Displayed are mean values 
with standard deviation. Significance is given by one-tailed nonparametric Mann–Whitney U test calculation 
and is shown by asterisks (**p ≤ 0.001). Compared are gene copies per 100 mL in (i) raw influent with effluent 
after physicochemical and biological treatments and (ii) in effluent after physicochemical and biological 
treatments with effluent after subsequent ozone treatment. LOD – limit of detection.
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Abundance of facultative pathogenic bacteria in water samples. E. coli, K. pneumoniae, A. bau-
mannii, P. aeruginosa, and enterococci were quantified using species-specific gene markers after PMA treatment 
of the samples (Fig. 4). E. coli followed by enterococci and A. baumannii were the most predominant target spe-
cies in the influent, with abundances of 6.90 ×  104, 8.41 ×  103 and 7.47 ×  103 cell equivalents per 100 mL, respec-
tively. P. aeruginosa exhibited the lowest concentration of 4.32 ×  101 cell equivalents per 100 mL.
After the physicochemical and biological treatments, all target species were reduced significantly (p < 0.001). 
Moreover, K. pneumoniae was reduced < LOD. After the subsequent ozonation, a nonsignificant reduction in E. 
coli and enterococci was observed, whereas P. aeruginosa was significantly reduced < LOD (p < 0.001).
Occurrence of antimicrobial residues in water samples. Of the wastewater samples, 55.6% 
(n = 10/18) were positive for antibiotic residues, which were detected only in the influent and effluent of the 
in-house WWTP after conventional treatment, indicating that antimicrobials were removed during ozona-
tion (Table 1). The most prevalent antimicrobial classes detected were macrolides (38.9%, 7/18), sulfonamides 
(16.7%, 3/18), and fluoroquinolones (11.1%, 2/18).
Discussion
This study provides insights regarding the occurrence and impact of ESKAPE bacteria, including ESBL-producing 
E. coli, ARGs and antimicrobial residues, in wastewater samples from a German poultry slaughterhouse that 
might be disseminated to the environment. Furthermore, we evaluated the efficacy of ozonation treatment of 
wastewater for a reduction in bacterial loads and ARGs.
Figure 4.  Abundance of facultative pathogenic bacteria in influent and effluent after physicochemical and 
biological treatments and subsequent ozone treatment. Displayed are mean values with standard deviation. 
Significance is given by one-tailed nonparametric Mann–Whitney U test calculation and is shown by asterisks 
(**p ≤ 0.001). Compared are gene copies per 100 mL in (i) raw influent with effluent after physicochemical and 
biological treatments and (ii) in effluent after physicochemical and biological treatments with effluent after 
subsequent ozone treatment. LOD – limit of detection.
Table 1.  Antimicrobial residues detected in wastewater samples from the in-house WWTP of the examined 
poultry slaughterhouse. a Abbreviations for antimicrobial agents: TYL tylosin, SXM sulfamethoxazole, 
SDD sulfadimidine, ENR enrofloxacin, AMP ampicillin. b N—Sampling number. c Only samples with 
concentrations > LOQ were used for the evaluation.
Antimicrobiala [µg/L]
Influent (n = 6)
Effluent after physicochemical and 
biological treatments (n = 6) Frequency c[%]
Nb1 N2 N3 N4 N6 N1 N2 N3 N4 N5
TYL 3.7 0.83 12 0.27 0.24 0.08 0.11 38.9
SXM 0.06 0.04 11.1
SDD 0.06 5.6
ENR 3.9 0.47 11.1
AMP  < LOQ -
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The high number of notified 3MDRO E. coli and K. pneumoniae isolates might be caused by the use of 
β-lactams (e.g., cephalosporines, penicillins) and fluoroquinolones for the treatment of animal infections in 
the veterinary  medicine20. Cephalosporines and fluoroquinolones belong to the veterinary critically important 
antimicrobial agents (VCIAs) and are crucial for combating specific infectious diseases (e.g., septicaemias and 
respiratory and enteric diseases) in livestock. However, the use of VCIA also affects public health, as these anti-
microbials are also considered the highest priority critically important antimicrobials (HPCIAs) for  humans21.
Clinically associated fluoroquinolone resistance is mainly caused by chromosomal mutations in the quinolone 
resistance-determining regions (QRDRs) of gyrA and parC22,23. Furthermore, the cooccurrence of plasmid-
mediated quinolone resistance (PMQR) genes and QRDR mutations can lead to high resistance (fluoro)quinolone 
 phenotypes24. Recently, high percentages of ciprofloxacin resistance in ESBL-producing E. coli (50.5%) and K. 
pneumoniae (67.9%) from process and wastewater of poultry slaughterhouses have been  reported17. Moreover, 
Savin et al. also notified a high number of PMQRs (31.4%) in 3MDRO extraintestinal pathogenic E. coli (ExPEC) 
and ESBL-producing K. pneumoniae (100%) from poultry  slaughterhouses16.
The detected concentrations of enrofloxacin in untreated wastewater exceeded its Predicted No Effect Con-
centrations (PNECs) for resistance selection of 0.064 µg/L25, indicating that the withdrawal period of enro-
floxacin might not be strictly adhered to. This selective pressure might further facilitate the development of 
fluoroquinolone resistance in clinically relevant bacteria. Thus, the use of fluoroquinolones should be restricted 
to individual treatments and no longer permitted for general medication of poultry herds. Thus, we strongly 
recommend forcing the development of alternative antimicrobial-free treatment strategies to avoid the use of 
similar antimicrobials in different compartments.
The high abundance of β-lactam (bla) resistance genes in the investigated cephalosporin-resistant E. coli 
correlates well with the detected prevalence of blaTEM-1, blaTEM-52, blaTEM-116, blaSHV-1, blaSHV-12 and blaCTX-M-1 in 
isolates of livestock wastewater and poultry  products26,27. In general, ESBL-producing E. coli carrying diverse 
virulence determinants (i.e. for human colonization and infection) are widely disseminated in German poultry 
 production16,28. While other reports have detected up to 16.2% ExPEC isolates from poultry wastewater, no 
isolate of this study was assigned to the ExPEC phylogroups B2 or  D16.
The development and dissemination of ESBL-producing Enterobacteriaceae are not only promoted by the use 
of β-lactams in veterinary medicine but also facilitated by co- and cross-resistance through disinfectants, heavy 
metals, and other antimicrobials, since corresponding genes are often located on the same  plasmid29. The cooc-
currence of bla and mcr genes is of particular importance, since colistin was reintroduced into human therapy 
to treat infections caused by carbapenemase-producing Enterobacteriaceae (CPE) or multidrug-resistant A. 
baumannii and P. aeruginosa30. Moreover, mobile colistin resistance genes (esp. mcr-1) is considered to originate 
from  livestock31. Colistin-resistant Enterobacteriaceae carrying mcr-1 on a wide variety of transmissible plasmids 
have already been reported from German process waters and wastewaters of livestock slaughterhouses, municipal 
WWTPs, and  hospitals18,32.
Reports on the occurrence of ARGs in livestock wastewater conferring resistance to HPCIA have already 
been  published33. However, there is a lack of qualitative and quantitative data for German slaughterhouses. We 
detected high abundances of the mcr-1, blaCMY-2 and blaCTX-M genes in untreated wastewater, which is worrying 
since they confer resistance to HPCIA in  humans20. Their potential incorporation into clinically relevant bacteria 
might narrow antimicrobial treatment options and compromise their efficacy in cases of infection, especially if 
resistance against different last resort antibiotics (e.g., carbapenemases, mcr)  occurs34,35. The human impact of 
livestock as a reservoir for combinations of antimicrobials of the last resort (i.e. blaNDM-1/mcr-1) have already 
been  described36,37.
Of special concern is the occurrence of the carbapenemase gene blaOXA-48 among investigated wastewater 
samples detected by molecular-based methods. As selective cultivation did not yield any carbapenem-resistant 
isolates, culturable carbapenemase-producing Enterobacteriaceae can be excluded as predominant hosts for 
blaOXA-48. Thus, molecular detection of carbapenemase genes in environmental samples has only limited value, 
as the host species is not identified. However, other studies demonstrated different transferable plasmids carry-
ing the blaOXA-48 gene in Enterobacteriaceae, which might not be cultivable or underrepresented in the analysed 
isolates of our  study38,39. A probable reservoir for blaOXA-48 might be Shewanella spp., as this gene naturally occurs 
in these bacteria. As Shewanella spp. are not of particular clinical relevance, they might play a role as drivers of 
blaOXA-48 spread to clinically relevant bacteria (i.e. ESKAPE)40. The slight increase of blaOXA-48 in effluent samples 
treated with zone might indicate its selective properties regarding antibiotic-resistant, and more ozone-tolerant 
bacterial  species41.
The presence of the vanA gene in untreated wastewater is worrying, as vancomycin also represents an anti-
microbial of the last resort that is critically important for human  medicine21. However, cultural analysis for 
vancomycin-resistant enterococci (VRE) was negative, which is in line with other studies reporting the absence 
or rare occurrence of VRE in livestock wastewater from German  slaughterhouses17,19. This might indicate the 
presence of vancomycin-variable enterococci (VVE), which are vanA-positive but phenotypically susceptible 
to  vancomycin42. Because of their susceptibility to vancomycin, traditional methods fail to detect VVE. vanA 
encodes inducible high-level resistance to glycopeptides, and VVE have the ability to revert into vancomycin-
resistant phenotypes upon vancomycin  exposure42. However, glycopeptides are not approved for the treatment 
of livestock in the EU, and the use of avoparcin in feed as a growth promoter was banned in Germany in  199643. 
Moreover, after treatments in WWTPs, vanA and enterococci were reduced below the detection limit. Thus, the 
role of agriculture in Germany in the development of glycopeptide-resistant enterococci is less significant than 
that in the general community and hospitals. Pseudomonas spp., Aeromonas spp. and Raoutella spp. isolated from 
surface water have also been reported to carry the vanA  gene44.
However, coselection by macrolides, tetracycline, or copper might play an important role in maintaining the 
persistence of VRE in  livestock45–47. Macrolides and tetracyclines together with penicillins and sulfonamides 
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belong to the VCIA, for which there are fewer alternatives  available48. In 2018, 571.7 tons of antimicrobials of 
these classes were sold to veterinarians in Germany, making up 79.1% of the total  amount49. Interestingly, the 
supplied quantities of these antimicrobials correlate well with the abundances of particular ARGs in the investi-
gated wastewater samples. Moreover, high abundances of ermB, sul1 and tetM genes are in line with other studies 
reporting a high prevalence of these resistance determinants in isolates recovered from livestock wastewater and 
poultry products, inter alia, in ExPEC and MDR E. coli  isolates16.
The high abundance of ermB in wastewater is critical since ermB encodes resistance to macrolides, which are 
HPCIAs for human medicine and are crucial for the treatment of severe Campylobacter infections, particularly in 
 children21. Furthermore, erm genes could be transferred to gram-positive pathogens (e.g., staphylococci, strepto-
cocci, enterococci), resulting in  MLSB (macrolide, lincosamide, streptogramin B) cross-resistance, compromising 
the efficacy of further antibiotics such as erythromycin and  clindamycin50. This might be the reason for the high 
resistance rates of MRSA to erythromycin and its combination with clindamycin. MRSA of CC9 and CC398, 
which were detected in this study, have already been reported in wastewater from poultry slaughterhouses and 
in retail poultry  products17,51. They were also isolated from human infections, especially in regions with high 
livestock production, underlying their zoonotic  potential52. Interestingly, the detected concentration of tylosin 
(12 µg/L) might exert selective pressure on species with resistance to macrolides, including MRSA, as it exceeded 
its PNEC of 4 µg/L. However, detected antimicrobials were eliminated after ozonation, which is in line with other 
studies reporting high degradation rates (70–100%) of macrolides as well as sulfonamides and fluoroquinolones 
depending on ozone dose and reaction  time53. The removal of various organic micropollutants, which might not 
be reduced by other advanced treatment technologies, e.g., ultrafiltration, is an advantage of ozonation.
However, additional ozonation following conventional treatment did not significantly reduce the loads of 
facultative pathogenic bacteria, which might be due to different factors, such as ozonation time, concentration 
of the applied ozone, wastewater composition and physical characteristics of the examined  organisms41. It is 
important to note that a high number of bacterial cells in wastewater might be aggregated in flocs, protecting 
the inner cells from the damaging effects of ozone. Comparable results regarding microbial reduction rates were 
observed in German municipal WWTPs after conventional  treatment54.
Conventional treatment significantly reduced the abundances of ARGs conferring resistance to clinically 
relevant antimicrobials. Some of them (i.e., mcr-1, blaCTX-M-32) were further reduced below the limit of detection 
after subsequent additional treatment with ozone, underlying the importance of advanced treatment. However, 
despite the significant reduction through conventional and advanced treatments, effluents still exhibited relatively 
high concentrations of some ARGs, e.g., sul1, ermB and blaOXA-48 (>  102 copies/100 mL). Similar reduction rates 
were reported by Czekalski and  colleagues41. Ozonation does not show the best effect on the reduction of ARGs 
in comparison to other methods, e.g., chlorination or ultrafiltration. This might be due to low ozone dosages 
frequently used in  practice13,55. However, increasing the amount of ozone might lead to the release of harmful 
products to the environment and have an ecotoxicological  effect56. Applying additional filtration steps (e.g., 
charcoal or sand filtration) after ozonation to remove remaining ozone and unwanted byproducts may result 
in bacterial  regrowth13. Moreover, the receiving water bodies can support bacterial regrowth if they contain 
the necessary nutrients. Iakovides et al. reported the regrowth of total and antibiotic-resistant E. coli after the 
stress caused by ozone was relieved, indicating the importance of proper setting of ozonation  parameters53. For 
wastewater exhibiting high concentrations of ARGs and antibiotic-resistant bacteria, a combination of oxidative, 
adsorptive (charcoal or sand filtration), and membrane-based technologies should be considered to interrupt 
dissemination of (facultative) pathogenic antibiotic-resistant bacteria to the environment.
Material and methods
Examined poultry slaughterhouse and its wastewater management. The investigated poultry 
slaughterhouse exhibited a capacity of > 100,000 slaughtered chickens per day by producing 3,600  m3 wastewater 
that was treated in an in-house wastewater treatment plant (WWTP) before being discharged into a preflooder 
and a receiving waterbody (i.e., river).
On-site treatment of wastewater is based on physicochemical, biological, and advanced oxidation processes. 
First, the wastewater was mechanically pretreated using screeners and sieves. Fat and greases are removed using 
grease traps. Afterwards, the wastewater is treated by dissolved air flotation with a subsequent biological treat-
ment by activated sludge. Additionally, the in-house WWTP was equipped with an ozone system (Xylem Water 
Solutions Deutschland GmbH, Großostheim, Germany). The ozone dosage used was 75 g/m3, and the contact 
time varied between 15 and 30 min, depending on the water flow rate.
Sampling and sample preparation. In a two-month period, the in-house WWTP of a poultry slaugh-
terhouse was sampled six times with a minimum time interval of 1 week. During sampling, a total of 18 samples 
were collected representing the influent (n = 6), the effluent after physicochemical and biological treatments 
(n = 6) and the effluent after ozone treatment (n = 6). The samples were taken as qualified samples according to 
the German standard methods for the examination of water, wastewater, and sludge (DIN 38402-11:2009-02)57. 
Therefore, five subsamples of 200 mL in two-minute sampling intervals were collected and mixed. The samples 
were transported to the laboratory in a Styrofoam box cooled to 5 ± 2 °C and were further processed within 24 h. 
Influent samples were manually filtered using stomacher strainer bags with a tissue filter (pore size, 0.5 mm; 
VWR, Radnor, PA, USA) to remove large particles.
Cultivation, identification and susceptibility testing of target bacteria. The samples were sub-
jected to culturing on selective media to isolate gram-negative ESBL-producing and carbapenemase-producing 
Enterobacteriaceae (E. coli, Klebsiella spp., Enterobacter spp., Citrobacter spp. ), nonfermenting A. baumannii 
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and P. aeruginosa, as well as MRSA and vancomycin-resistant enterococci (VRE). Detailed information on their 
cultivation procedures has already been  published17.
Species identification was performed by MALDI-ToF MS (bioMérieux, Marcy-l’Étoile, France) equipped 
with Myla software. The isolates were purified on Columbia agar supplemented with 5% sheep blood, and cryo-
preservation at − 80 °C in cryotubes (Mast Diagnostics, Reinfeld, Germany) was used for storage. Isolated target 
bacteria were further subjected to antimicrobial susceptibility testing by the microdilution method according 
to protocols of the European Committee on Antimicrobial Susceptibility Testing (EUCAST v 11.0) using the 
Micronaut-S MDR MRGN-Screening system for Gram-negatives and the MICRONAUT-S MRSA/GP testing 
panel for Gram-positive bacteria (MERLIN, Gesellschaft für mikrobiologische Diagnostika GmbH, Bornheim-
Hersel, Germany)58. The results were evaluated based on clinical cut-off values provided by  EUCAST59. The 
multidrug-resistance phenotype (3MDRO) was defined based on combined resistance to piperacillin (PIP), 
cefotaxime (CTX) and/or ceftazidime (CAZ), and ciprofloxacin (CIP) as previously  described60.
Detection and analysis of selected antibiotic resistance genes (ARGs) in target bacteria. Tem-
plate DNA for PCRs was prepared by boiling bacterial suspensions in 10 mM Tris–EDTA pH 8.0 (Sigma-Aldrich, 
St. Louis, MO, USA) according to Aldous et al.61. Enterobacterales with phenotypic resistance to 3rd-generation 
cephalosporins were screened by PCR for β-lactamase (bla) genes encoding enzymes SHV, TEM, and CTX-M 
(groups 1, 2, 8 and 9) as previously  described62–64. Isolates of the A. calcoaceticus-baumannii complex and P. 
aeruginosa were examined for the presence of blaPER, blaGES, and blaVEB by PCR as  described65. Colistin-resistant 
isolates (MIC > 2 mg/L) were screened for mcr-1 to mcr-5 as well as mcr-6 to mcr-9 genes using multiplex PCR 
protocols as described by Rebelo et al.66 and Borowiak et al.67, respectively. The obtained PCR amplicons were 
purified with the innuPREP DOUBLEpure Kit (Analytik Jena AG, Jena, Germany) and subjected to Sanger 
sequencing at Microsynth Seqlab (Göttingen, Germany).
Molecular typing of resistant bacterial isolates. Phylotyping of E. coli isolates (A, B1, B2, C, D, E, F, 
clade I-V) was conducted as previously  described68. MRSA isolates were spa-typed by amplifying and sequenc-
ing the Staphylococcus protein A repeat region according to Harmsen et al.69. The Ridom spa server database 
(http:// www. spase rver. ridom. de) was used for assignment of spa types.
DNA extraction from water samples, quantification of antibiotic resistance genes (ARGs) and 
taxonomic gene markers. Volumes of 50 mL, 200 mL and 400 mL of influent, effluent after physicochem-
ical and biological treatments and effluent after ozone treatment were subjected to DNA isolation after treatment 
with 0.25 mM propidium monoazide (PMA) (BLU-V viability PMA-kit, Qiagen GmbH, Hilden, Germany) as 
previously  described12,14.
Antibiotic resistance genes (ARGs) that are most frequently detected in German urban wastewaters (sul1, 
ermB, blaTEM, tetM) as well as “intermediate and rare abundant”, which encode resistances to “Highest Priority 
Critically Important Antimicrobials” (blaCTX-M-15, blaCTX-M-32, blaCMY-2, mcr-1, blaOXA-48, blaNDM-1, vanA), were 
quantitatively amplified as previously  published13,70. Furthermore, the facultative pathogenic bacteria E. coli 
(yccT), K. pneumoniae (gltA), A. baumannii (secE), P. aeruginosa (ecfX), and enterococci (23S rDNA) were 
 quantified13,70. For qPCR analysis, a Bio-Rad Cycler CFX96 (CFX96 Touch Deep Well Real-Time PCR Detection 
System, Bio-Rad, Munich, Germany) and SYBR Green qPCR approach according to Hembach et al.70 and Jäger 
et al.12 were used. All samples were measured in technical triplicates. Cell equivalents were calculated accord-
ing to Hembach et al.70 and normalized to 100 mL of water sample. In addition, a one-tailed nonparametric 
Mann–Whitney U test (Origin 8.1, OriginLab Corporation, Northampton, USA) was performed to identify 
the significance of the reduction in target genes during conventional and advanced wastewater treatments. Full 
primer sequences, qPCR reagent rations, thermal conditions and corresponding limit of detections (LODs) are 
listed in Supplemental Material (Tables S1, S2).
Determination of antimicrobial residues. Water samples were analysed for 45 antibiotics and two 
metabolites (N-acetylsulfamethoxazole and anhydroerythromycin) by high-performance liquid chromatogra-
phy (HPLC) coupled to tandem mass spectrometry (MSMS) after dilution and filtration through hydrophilic 
PTFE filters (Macherey–Nagel, Düren, Germany) as previously  described71. The analysed antibiotics belong to 
the following substance classes: β-lactams (i.e. penicillins, cephalosporins and carbapenems), tetracyclines, fluo-
roquinolones, sulfonamides (as well as their synergist trimethoprim), macrolides including tylosin and spiramy-
cin, lincosamides, glycopeptides, oxazolidinones, and nitroimidazoles. All analysed antibiotics, including their 
limit of quantification (LOQ), are given in Supplemental Material Table S3. The LOD of each individual analyte 
was one-third of the respective LOQ.
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